hidradenitis suppurativa and glp 1 Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive Therapy for in Patients With Overweight/Obesity: A Narrative Review of Efficacy, Safety, Quality‐of‐Life Outcomes - Almukhadeb - 2026 GLP-1 Medications for Hidradenitis Suppurativa:
Description
GLP-1 RAs were created after endogenous glucagon-like peptide-1 (GLP-1) was discovered in the 1980s by Jens Juul Host and Joel Habener [1,2]
when analyzed individually, saxagliptin was significantly associated with the increased risk of HF (RR 1.215
They argue its advertising and disclosure provisions repeat rules that already exist and could chill ordinary clinical discussions between pharmacists and patients
Dehydration worsens side effects, particularly nausea, fatigue, and constipation
Obesity and Obstructive Sleep Apnea: Or Is It OSA and Obesity
The flat-pricing structure means patients are not charged more as their clinician adjusts their dosage during treatment - a distinction that matters over the course of a multi-month program
